Differential effects of renin–angiotensin–aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension
出版年份 2012 全文链接
标题
Differential effects of renin–angiotensin–aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension
作者
关键词
-
出版物
JOURNAL OF HYPERTENSION
Volume 31, Issue 2, Pages 393-403
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2012-12-12
DOI
10.1097/hjh.0b013e32835b6c02
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
- (2013) Kenneth F. Schulz ANNALS OF INTERNAL MEDICINE
- Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients
- (2012) Agostino Virdis et al. EUROPEAN HEART JOURNAL
- The human sympathetic nervous system: its relevance in hypertension and heart failure
- (2012) G. Parati et al. EUROPEAN HEART JOURNAL
- Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways
- (2012) Ana M. Briones et al. HYPERTENSION
- Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin–angiotensin system activity in obese hypertensive patients
- (2012) Michael Boschmann et al. JOURNAL OF HYPERTENSION
- Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension
- (2012) Jens Jordan et al. JOURNAL OF HYPERTENSION
- Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients
- (2011) L. Siddiqi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mechanisms linking obesity to hypertension
- (2011) J. A. N. Dorresteijn et al. Obesity Reviews
- Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN Study
- (2011) Adam Whaley-Connell et al. CardioRenal Medicine
- Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis
- (2010) C. Vlachopoulos et al. EUROPEAN HEART JOURNAL
- Different Effects of Aliskiren and Losartan on Fibrinolysis and Insulin Sensitivity in Hypertensive Patients with Metabolic Syndrome
- (2010) R. Fogari et al. HORMONE AND METABOLIC RESEARCH
- Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis
- (2010) Yoichi Inaba et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome
- (2010) W Krone et al. JOURNAL OF HUMAN HYPERTENSION
- Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
- (2009) Scott D. Solomon et al. CIRCULATION
- Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance
- (2009) Sabine Perl et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial
- (2009) Roland E Schmieder et al. JOURNAL OF HYPERTENSION
- Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
- (2009) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation